Providing holistic care for patients with metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions.

This review article discusses metabolic dysfunction-associated steatotic liver disease (MASLD) as a highly prevalent con...

Continue ReadingProviding holistic care for patients with metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions.

The Precision Paradox: Why Modern Oncology Requires Treating Less – Selectively

World Cancer Day 2026 creates a rare pause in oncology – not for awareness, but for recalibration. The theme, United by Unique, lands at a moment when the science is…

Continue ReadingThe Precision Paradox: Why Modern Oncology Requires Treating Less – Selectively

Incorporating artificial intelligence into imaging for surveillance and diagnosis of liver cancer: Innovations, challenges, and clinical translation.

This publication is a narrative review on the role of artificial intelligence (AI) in the management of primary liver ca...

Continue ReadingIncorporating artificial intelligence into imaging for surveillance and diagnosis of liver cancer: Innovations, challenges, and clinical translation.